{{Rsnum
|rsid=77905
|Gene=DBH
|Chromosome=9
|position=133652975
|Orientation=minus
|GMAF=0.3545
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=DBH
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 22.1 | 54.0 | 23.9
| HCB | 81.8 | 18.2 | 0.0
| JPT | 80.5 | 16.8 | 2.7
| YRI | 32.9 | 51.4 | 15.8
| ASW | 33.3 | 43.9 | 22.8
| CHB | 81.8 | 18.2 | 0.0
| CHD | 85.3 | 11.9 | 2.8
| GIH | 29.7 | 42.6 | 27.7
| LWK | 30.9 | 41.8 | 27.3
| MEX | 48.3 | 36.2 | 15.5
| MKK | 25.0 | 49.4 | 25.6
| TSI | 31.4 | 51.0 | 17.6
| HapMapRevision=28
}}Genetic variation in the dopamine pathway and smoking cessation.{{PMID|18781857}}

{{PMID Auto
|PMID=20350135
|Title=Prospective association of dopamine-related polymorphisms with smoking cessation in general care
}}

{{PMID Auto
|PMID=16272956
|Title=CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents.
}}

{{PMID Auto
|PMID=18486967
|Title=A community-based study of cigarette smoking behavior in relation to variation in three genes involved in dopamine metabolism: Catechol-O-methyltransferase (COMT), dopamine beta-hydroxylase (DBH) and monoamine oxidase-A (MAO-A).
|OA=1
}}

{{PMID Auto
|PMID=19673036
|Title=Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}